SEC Comment Letter 0000000000-25-002593 to enVVeno Medical Corp (NVNO)
enVVeno Medical Corp
Date: March 10, 2025 · CIK: 0001661053 · Accession: 0000000000-25-002593
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285474
Letter
Re: enVVeno Medical Corporation Registration Statement on Form S-3 Filed February 28, 2025 File No. 333-285474 Dear Robert A. Berman:
March 10, 2025
Robert A. Berman Chief Executive Officer enVVeno Medical Corporation 70 Doppler Irvine, California 92618
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Matthew Bernstein, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 10, 2025 Robert A. Berman Chief Executive Officer enVVeno Medical Corporation 70 Doppler Irvine, California 92618 Re: enVVeno Medical Corporation Registration Statement on Form S-3 Filed February 28, 2025 File No. 333-285474 Dear Robert A. Berman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Matthew Bernstein, Esq. </TEXT> </DOCUMENT>